Indication
Fampridine Accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (EDSS 4-7).
Loading your page…
Loading your page…
Multiple Sclerosis
Marketing Authorisation Holder: Accord Healthcare S.L.U.
EMA Authorisation: 24/09/2020
INN: fampridine
AI Drug & Interaction Analysis
Free account required
Ask Osler about Fampridine Accord: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.